VADIMEZAN SODIUM
UNII C35T92HIZM

Substance Identification & Data

This profile provides standardized clinical and technical data for Vadimezan Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C35T92HIZM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 129095-08-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C35T92HIZM

CAS Registry Number

129095-08-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VADIMEZAN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H13O4.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CUHSZPRXKQDLCJ-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216637

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23674529

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(c(=O)c3c(o1)c(CC(=O)[O-])ccc3)ccc(c2C)C.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vadimezan Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.